384 related articles for article (PubMed ID: 15082202)
21. [Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial].
Takahashi Y; Kuriyama M; Yamada S; Fujimoto Y; Takeuchi T; Doi T; Sakai S; Isogai K; Kanematsu M; Hayashi H; Fujihiro S; Hasegawa Y; Ehara H; Maeda S; Itoh F; Kobayashi S; Horie M; Matsuda S; Takeda A; Tei KH; Kawada Y
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1817-9. PubMed ID: 9382540
[TBL] [Abstract][Full Text] [Related]
22. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
Aikawa K; Irisawa C; Muraki O; Yamaguchi O; Shiraiwa Y; Noguchi M; Koguchi M; Yokoyama J; Ito K; Kumakawa K
Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401
[TBL] [Abstract][Full Text] [Related]
23. A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
Serretta V; Morgia G; Altieri V; Di Lallo A; Ruggiero G; Salzano L; Battaglia M; Falsaperla M; Zito A; Sblendorio D; Melloni D; Allegro R;
BJU Int; 2010 Jul; 106(2):212-7. PubMed ID: 20070299
[TBL] [Abstract][Full Text] [Related]
24. Intravesical chemotherapy with epirubicin: a dose response study.
Masters JR; Popert RJ; Thompson PM; Gibson D; Coptcoat MJ; Parmar MK
J Urol; 1999 May; 161(5):1490-3. PubMed ID: 10210379
[TBL] [Abstract][Full Text] [Related]
25. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
Liu B; Zhang Y; Wang Z; Ding Q; Chen B; Wang J; Jiang H
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):112-5. PubMed ID: 11955393
[TBL] [Abstract][Full Text] [Related]
26. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
Shichiri Y; Kanba T; Yoshida S; Arai Y
Hinyokika Kiyo; 1995 May; 41(5):359-64. PubMed ID: 7598036
[TBL] [Abstract][Full Text] [Related]
27. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
[TBL] [Abstract][Full Text] [Related]
28. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.
Cai T; Nesi G; Tinacci G; Zini E; Mondaini N; Boddi V; Mazzoli S; Bartoletti R
J Urol; 2008 Jul; 180(1):110-5. PubMed ID: 18485394
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer. Tokyo Women's Medical College Bladder Cancer Collaborating Group.
Ryoji O; Toma H; Nakazawa H; Goya N; Okumura T; Sonoda T; Kihara T; Tanabe K; Onizuka S; Tomoe H
Cancer Chemother Pharmacol; 1994; 35 Suppl():S60-4. PubMed ID: 7994789
[TBL] [Abstract][Full Text] [Related]
30. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y
Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
[TBL] [Abstract][Full Text] [Related]
31. Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
Okamura K; Ono Y; Kinukawa T; Matsuura O; Yamada S; Ando T; Fukatsu T; Ohno Y; Ohshima S;
Cancer; 2002 May; 94(9):2363-8. PubMed ID: 12015761
[TBL] [Abstract][Full Text] [Related]
32. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
[TBL] [Abstract][Full Text] [Related]
33. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
34. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
[TBL] [Abstract][Full Text] [Related]
35. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
[TBL] [Abstract][Full Text] [Related]
36. [Prophylaxis of recurrence in superficial bladder carcinoma by intravesical chemotherapy--comparative study between instillation of combined double anticancer agents and single anticancer agent].
Ikeda R; Chikazawa I; Kobayashi Y; Shiroma K; Nakade T; Suga K; Shiba N; Nakajima C; Moriyama M; Kawamura K; Miyazawa K; Tanaka T; Tsugawa R; Suzuki K; Sato H; Kikuyama A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):509-14. PubMed ID: 10097748
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
38. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML
Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
[TBL] [Abstract][Full Text] [Related]
39. [A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer].
Kawamura S; Fujioka T; Kubo T; Yoshida I; Takata K
Gan To Kagaku Ryoho; 1996 Mar; 23(4):465-70. PubMed ID: 8678499
[TBL] [Abstract][Full Text] [Related]
40. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
